Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway | |
Dai J.; Wei R.; Zhang P.; Kong B. | |
刊名 | Journal of Translational Medicine |
2019 | |
卷号 | 17期号:1 |
关键词 | Angiogenesis Cisplatin resistance Glycogen synthase kinase-3β/β-catenin signaling pathway MicroRNA-195-5p Ovarian cancer Phosphoserine aminotransferase 1 |
DOI | 10.1186/s12967-019-1932-1 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4531640 |
专题 | 山东大学 |
作者单位 | 1.Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University, No. 107, Wenhua West Road, Jinan, Shandong, 250012, China 2.[ We |
推荐引用方式 GB/T 7714 | Dai J.,Wei R.,Zhang P.,et al. Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway[J]. Journal of Translational Medicine,2019,17(1). |
APA | Dai J.,Wei R.,Zhang P.,&Kong B..(2019).Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.Journal of Translational Medicine,17(1). |
MLA | Dai J.,et al."Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway".Journal of Translational Medicine 17.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论